by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
Johnson & Johnson on Tuesday became the latest drugmaker to go to court to halt Medicare drug price negotiations established by the Inflation Reduction Act. The lawsuit increases the odds that negotiated prices won’t take effect on schedule, beginning in...
by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) has approved a treatment for the prevention of RSV among infants and toddlers, making it the first preventive drug for the common virus that surged last winter among small children. The FDA approved nirsevimab-alip, or Beyfortus,...
by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
For the first time, a semi-independent committee for the World Health Organization (WHO) said Thursday it has determined that aspartame, a popular artificial sweetener found in thousands of products like diet sodas and sugar-free gum, should be categorized as...
by Jessica Casebolt | Jul 31, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) on Thursday approved a birth control pill to be sold without a prescription for the first time in the United States, a milestone that could significantly expand access to contraception. The medication, called Opill, will become...
by Jessica Casebolt | Jul 13, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) is opening the way for more cancer drugs from China as the U.S. continues to deal with an ongoing shortage in key chemotherapy treatments. A spokesperson for the FDA confirmed Monday that the agency is permitting 10 additional...
by Jessica Casebolt | Jul 12, 2023 | Life Sciences, Tea Leaves
On Thursday, the US Food and Drug Administration (FDA) granted traditional full approval to the Alzheimer’s drug Leqembi. The Centers for Medicare and Medicaid Services (CMS) said Thursday that it will now expand coverage of the drug, broadening access for up to an...
Recent Comments